首页 | 本学科首页   官方微博 | 高级检索  
检索        


Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
Authors:K Solez  R B Colvin  L C Racusen  M Haas  B Sis  M Mengel  P F Halloran  W Baldwin  G Banfi  A B Collins  F Cosio  D S R David  C Drachenberg  G Einecke  A B Fogo  I W Gibson  D Glotz  S S Iskandar  E Kraus  E Lerut  R B Mannon  M Mihatsch  B J Nankivell  V Nickeleit  J C Papadimitriou  P Randhawa  H Regele  K Renaudin  I Roberts  D Seron  R N Smith  M Valente
Institution:Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada;Department of Pathology, Harvard Medical School and Massachusetts General Hospital, Boston, MA;Department of Pathology, Johns Hopkins University, Baltimore, MD;Department of Medicine, Division of Nephrology &Immunology, Alberta Transplant Applied Genomics Centre, University of Alberta, Edmonton, Canada;Division of Nephrology, Fondazione Ospedale Maggiore IRCCS, Mangiagalli, Milano, Italy;Division of Nephrology and Hypertension, The Mayo Foundation and Clinic, Rochester, MN;Division of Pathology and Renal Transplant Unit, University of São Paulo, Brasil;Department of Pathology, University of Maryland, Baltimore, MD;Department of Pathology, Vanderbilt University School of Medicine, Nashville, TN;Department of Pathology, University of Manitoba, Winnipeg, Canada;Department of Nephrology, Hospital Saint-Louis, Paris, France;Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, NC;Department of Nephrology, John Hopkins University, Baltimore, MD;Department of Morphology and Molecular Pathology, University Hospitals Leuven, Belgium;Transplantation Branch, National Institute of Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD;Institute for Pathology, University of Basel, Basel, Switzerland;Center for Transplant Research and Renal Research, Westmead Hospital, Sydney, Australia;Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC;Division of Transplantation Pathology, Department of Pathology, University of Pittsburgh, Pittsburgh, PA;Institute for Pathology, University of Vienna, Vienna, Austria;Department of Pathology, CHU Hotel Dieu, Nantes, France;Department of Cellular Pathology, John Radcliffe Hospital, Oxford, United Kingdom;Department of Nephrology, Hospital, Universitario de Bellvitge, Barcelona, Spain;Department of Medico-Diagnostic Sciences, University of Padua, Padua, Italy
Abstract:The 9th Banff Conference on Allograft Pathology was held in La Coruna, Spain on June 23–29, 2007. A total of 235 pathologists, clinicians and scientists met to address unsolved issues in transplantation and adapt the Banff schema for renal allograft rejection in response to emerging data and technologies. The outcome of the consensus discussions on renal pathology is provided in this article. Major updates from the 2007 Banff Conference were: inclusion of peritubular capillaritis grading, C4d scoring, interpretation of C4d deposition without morphological evidence of active rejection, application of the Banff criteria to zero-time and protocol biopsies and introduction of a new scoring for total interstitial inflammation (ti-score). In addition, emerging research data led to the establishment of collaborative working groups addressing issues like isolated 'v' lesion and incorporation of omics-technologies, paving the way for future combination of graft biopsy and molecular parameters within the Banff process.
Keywords:Acute allograft rejection  acute cellular rejection  acute rejection  allograft rejection  antibody-mediated rejection  Banff  Banff lesions  Banff schema  classification  chronic allograft nephropathy  chronic allograft rejection  genomic markers  GeneChip
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号